Serum-Dependence of Affinity-Mediated VEGF Release
from Biomimetic Microspheres
- Publication date
- Publisher
Abstract
Vascular
endothelial growth factor (VEGF) activity is highly regulated
via sequestering within the ECM and cell-demanded proteolysis to release
the sequestered VEGF. Numerous studies have demonstrated that VEGF
activity mediates cellular events leading to angiogenesis and capillary
formation in vivo. This has motivated the study of biomaterials to
sustain VEGF release, and in many cases, the materials are inspired
by the structure and function of the native ECM. However, there remains
a need for materials that can bind to VEGF with high specificity,
as the in vivo environment is rich in a variety of growth factors
(GFs) and GF-binding moieties. Here we describe a strategy to control
VEGF release using hydrogel microspheres with tethered peptides derived
from VEGF receptor 2 (VEGFR2). Using biomaterials covalently modified
with varying concentrations of two distinct VEGFR2-derived peptides
with varying serum stability, we analyzed both biomaterial and environmental
variables that influence VEGF release and activity. The presence of
tethered VEGF-binding peptides (VBPs) resulted in significantly extended
VEGF release relative to control conditions, and the resulting released
VEGF significantly increased the expansion of human umbilical vein
endothelial cells in culture. VEGF release rates were also strongly
influenced by the concentration of serum. The presence of Feline McDonough
Sarcoma-like tyrosine kinase 1 (sFlt-1), a serum-borne receptor fragment
derived from VEGF receptor 1, increased VEGF release rates, although
sFlt-1 was not sufficient to recapitulate the release profile of VEGF
in serum. Further, the influence of serum on VEGF release was not
due to protease activity or nonspecific VEGF interactions in the presence
of serum-borne heparin. VEGF release kinetics correlated well with
a generalizable mathematical model describing affinity-mediated release
of VEGF from hydrogel microspheres in defined conditions. Modeling
results suggest a potential mechanism whereby competition between
VEGF and multiple VEGF-binding serum proteins including sFlt-1, soluble
kinase insert domain receptor (sKDR), and α2-macroglobulin (α2-M)
likely influenced VEGF release from microspheres. The materials and
mathematical model described in this approach may be useful in a range
of applications in which sustained, biologically active GF release
of a specific GF is desirable